Published Paper Details:

Background: Escherichia coli continue to be the most prevalent causal organism for UTIs, which are among the most prevalent bacterial infections observed in typical clinical settings. The dependability of traditional empirical regimens has been undermined by the increasing appearance of multidrug-resistant uropathogens. To support sensible prescribing, region-specific antibiograms are required, especially in central India where there is a dearth of available data. Objectives: To ascertain E. coli frequency in urine culture isolates and to describe its profile of antibiotic sensitivity, including the prevalence of multidrug resistance (MDR). Methods: Over the course of eighteen months, a cross-sectional research was carried out at the microbiology department of a tertiary care teaching hospital in Indore, Madhya Pradesh. Clinically suspected UTI patients provided 350 mid-stream clean-catch urine specimens. The calibrated loop technique was used to process the specimens on CLED and MacConkey agar, and >=10 CFU/mL was considered serious bacteriuria. Standard biochemical processes were used to identify E. coli.Mueller-Hinton agar was tested for antibiotic susceptibility using the Kirby-Bauer disc diffusion method in accordance with CLSI M100 (2023) criteria. Non-susceptibility to at least one agent in three or more antimicrobial classes was the definition of MDR according to the Magiorakos criterion. Results: 97 (27.7%) of the 350 specimens that were processed had substantial bacteriuria. Pseudomonas aeruginosa (9.3%) and Klebsiella pneumoniae (11.3%) were the next most common isolates, with E. coli accounting for 60 out of 97 culture-positive samples (61.9%). 62.9% of all positive cultures came from people between the ages of 20 and 49. The 60 E. Coli isolates showed the greatest levels of resistance to ampicillin (86.7%), cotrimoxazole (66.7%), ciprofloxacin (63.3%), and third-generation cephalosporins (46.7 to 60.0%). The best activity was maintained by amikacin (21.7%), nitrofurantoin (15.0%), piperacillin-tazobactam (13.3%), and imipenem (6.7%). Outpatient isolates had a slightly higher MDR rate (97.6%) than inpatient isolates (89.5%), with 57 out of 60 isolates (95.0%) meeting the criteria for multidrug resistance. Conclusions: Resistance to commonly prescribed oral agents has reached a level at which empirical use of ampicillin, cotrimoxazole or fluoroquinolones is no longer justifiable in this setting. While carbapenems, aminoglycosides, and ?-lactamase-inhibitor combos ought to be preserved for difficult or hospital-acquired infections, nitrofurantoin is still a reasonable option for simple lower UTIs in the community. A functional antimicrobial stewardship program and routine urine culture prior to starting treatment are now required, not optional.